Filtered By:
Source: Cancer Biomarkers : Section A of Disease Markers
Cancer: Squamous Cell Carcinoma
This page shows you your search results in order of date.
Order by Relevance | Date
Total 265 results found since Jan 2013.
Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencing
CONCLUSIONS: Our bioinformatics analysis identified KCNJ18, GPRIN2, TEKT4, HRNR, FOLR3, ESSRA, CTBP2, MPRIP, TBP, and FBXO6 may contribute to progression in NSCLC and could be used as new biomarkers for the treatment. The mechanism by which GPRIN2, KCNJ12, and TEKT4 contribute to tumorigenesis is unclear, but our results suggest they may play an important role in NSCLC and it is worth investigating in future.PMID:37694353 | DOI:10.3233/CBM-220211
Source: Cancer Biomarkers : Section A of Disease Markers - September 11, 2023 Category: Cancer & Oncology Authors: Varsha Singh Amit Katiyar Prabhat Malik Sunil Kumar Anant Mohan Harpreet Singh Deepali Jain Source Type: research
Advances in SEMA3F regulation of clinically high-incidence cancers
Cancer Biomark. 2023 Aug 12. doi: 10.3233/CBM-230085. Online ahead of print.ABSTRACTCancer has become a leading cause of morbidity and mortality in recent years. Its high prevalence has had a severe impact on society. Researchers have achieved fruitful results in the causative factors, pathogenesis, treatment strategies, and cancer prevention. Semaphorin 3F (SEMA3F), a member of the signaling family, was initially reported in the literature to inhibit the growth, invasion, and metastasis of cancer cells in lung cancer. Later studies showed it has cancer-inhibiting effects in malignant tumors such as breast, colorectal, ova...
Source: Cancer Biomarkers : Section A of Disease Markers - August 21, 2023 Category: Cancer & Oncology Authors: Chaofeng Wang Dezhi Song Qian Huang Qian Liu Source Type: research
